{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-000639","form_type":"8-K","ticker":"TECH","cik":"0000842023","company_name":"BIO-TECHNE Corp","filed_at":"2025-02-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.488483+00:00","generated_at":"2026-05-27T03:08:34.751113+00:00","sec_items":["2.02","5.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Bio-Techne Q2 organic revenue +9% to $297M, adjusted EPS $0.42; declares $0.08 dividend","bullets":["Q2 organic revenue up 9% to $297.0M; GAAP EPS $0.22 vs $0.17, adjusted EPS $0.42 vs $0.40.","Protein Sciences segment grew 8% organic; Diagnostics & Spatial Biology grew 12% organic.","Declared $0.08 per share quarterly dividend, payable Feb 28, 2025 to holders of record Feb 17, 2025.","Dr. Amy Herr appointed independent director effective Feb 1, 2025; serves on Science & Technology Committee."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-000639","json":"https://secwatch.observer/filing/0001558370-25-000639.json","markdown":"https://secwatch.observer/filing/0001558370-25-000639.md","text":"https://secwatch.observer/filing/0001558370-25-000639.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/842023/000155837025000639/0001558370-25-000639-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/842023/000155837025000639/tech-20250130x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T03:08:34.751113+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d379dc47e4","claim":"Amy Herr was appointed as Independent Director at BIO-TECHNE Corp.","evidence_excerpt":"On January 30, 2025, Bio-Techne Corporation (the “Company”) appointed Dr. Amy Herr to the Company’s Board of Directors as an independent director.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/842023/000155837025000639/0001558370-25-000639-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Independent Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}